Brief: Cipher Pharmaceuticals says is working with advisor to consider strategic alternatives
31/10/2016 17:45
Oct 31 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* Cipher Pharmaceuticals responds to request for comment
from IIROC
* Is working with an advisor to consider various strategic
alternatives potentially available
* Advisor was engaged as part of previously announced
strategic review being undertaken by Cipher's board of directors
Source text for Eikon: ID:nCNWmdkS7a
Further company coverage: CPH.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million